title: Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.
abstract: Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment of many patients with acute myeloid leukemia (AML). Despite extensive study, the appropriate role and timing of allogeneic and autologous transplantation in AML are poorly defined. This review critically analyzes the extensive literature, focusing on the recent advances, and provides practical recommendations for the use of HSCT in AML.
authors.affiliation: Division of Hematology & Oncology, Arthur G. James Cancer Hospital, Ohio State University, Columbus, Ohio, USA.
authors.forename: Mehdi
authors.initials: M
authors.lastname: Hamadani
authors.forename: Farrukh T
authors.initials: FT
authors.lastname: Awan
authors.forename: Edward A
authors.initials: EA
authors.lastname: Copelan
mesh_terms: D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D017410:Practice Guidelines as Topic; D019172:Transplantation Conditioning